OPKOPKO Health, Inc.

$933M

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$180M-53.4% YoY

Gross Profit

$31M17.4% margin

Operating Income

-$88M-48.9% margin

Net Income

-$86M-47.9% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-42.0%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$40M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$596M

Stockholders' Equity

$1.6B

Cash & Equivalents

$181M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$180M	$386M	-53.4%
Gross Profit	$31M	$142M	-77.9%
Operating Income	-$88M	$38M	-332.2%
Net Income	-$86M	$29M	-399.6%

Revenue Segments

Service

$143M79%

Product

$32M18%

Transfer of Intellectual Property and Other

$5M3%

Geographic Segments

UNITED STATES

$150M83%

CHILE

$14M8%

IRELAND

$7M4%

SPAIN

$5M3%

MEXICO

$4M2%

ISRAEL

$251,0000%

Other Countries

$174,0000%

OPK Q3 2022 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena